C-C Motif Chemokine Receptor 4 (CCR4) inhibitors, which mediate tumor trafficking of regulatory T cells (Tregs), lead to decreased Treg frequency and increased antitumor activity; however, CCR4 inhibitors are used in combination with CPI to improve antitumor efficacy (16). The gene discussed is CCR4; the disease is neoplasm.